Citation: M. Degasparo et N. Levens, DOES BLOCKADE OF ANGIOTENSIN-II RECEPTORS OFFER CLINICAL BENEFITS OVER INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME, Pharmacology & toxicology, 82(6), 1998, pp. 257-271
Citation: Rl. Webb et al., SYNERGISTIC EFFECTS OF COMBINED CONVERTING-ENZYME INHIBITION AND ANGIOTENSIN-II ANTAGONISM ON BLOOD-PRESSURE IN CONSCIOUS TELEMETERED SPONTANEOUSLY HYPERTENSIVE RATS, Journal of hypertension, 16(6), 1998, pp. 843-852
Authors:
MARTINEZ JM
PRIETO I
RAMIREZ MJ
DEGASPARO M
HERMOSO F
ARIAS JM
ALBA F
RAMIREZ M
Citation: Jm. Martinez et al., SEX-DIFFERENCES AND AGE-RELATED-CHANGES IN HUMAN SERUM AMINOPEPTIDASE-A ACTIVITY, Clinica chimica acta, 274(1), 1998, pp. 53-61
Authors:
MADRID MI
GARCIASALOM M
TORNEL J
DEGASPARO M
FENOY FJ
Citation: Mi. Madrid et al., EFFECT OF INTERACTIONS BETWEEN NITRIC-OXIDE AND ANGIOTENSIN-II ON PRESSURE DIURESIS AND NATRIURESIS, American journal of physiology. Regulatory, integrative and comparative physiology, 42(5), 1997, pp. 1676-1682
Authors:
COX MH
O SJ
DEGASPARO M
MUKHERJEE R
HEWETT KW
SPINALE FG
Citation: Mh. Cox et al., MYOCARDIAL ELECTROPHYSIOLOGICAL PROPERTIES IN THE PRESENCE OF AN AT(1) ANGIOTENSIN-II RECEPTOR ANTAGONIST, Basic research in cardiology, 92(3), 1997, pp. 129-138
Authors:
MADRID MI
GARCIASALOM M
TORNEL J
DEGASPARO M
FENOY FJ
Citation: Mi. Madrid et al., INTERACTIONS BETWEEN NITRIC-OXIDE AND ANGIOTENSIN-II ON RENAL CORTICAL AND PAPILLARY BLOOD-FLOW, Hypertension, 30(5), 1997, pp. 1175-1182
Citation: L. Merabet et al., DOSE-DEPENDENT INHIBITORY EFFECTS OF ANGIOTENSIN-II ON VISUAL RESPONSES OF THE RAT SUPERIOR COLLICULUS - AT(1) AND AT(2) RECEPTOR CONTRIBUTIONS, Neuropeptides, 31(5), 1997, pp. 469-481
Authors:
WALDMEIER F
FLESCH G
MULLER P
WINKLER T
KRIEMLER HP
BUHLMAYER P
DEGASPARO M
Citation: F. Waldmeier et al., PHARMACOKINETICS, DISPOSITION AND BIOTRANSFORMATION OF [C-14] RADIOLABELED VALSARTAN IN HEALTHY MALE-VOLUNTEERS AFTER A SINGLE ORAL DOSE, Xenobiotica, 27(1), 1997, pp. 59-71
Authors:
MULLER P
FLESCH G
DEGASPARO M
GASPARINI M
HOWALD H
Citation: P. Muller et al., PHARMACOKINETICS AND PHARMACODYNAMIC EFFECTS OF THE ANGIOTENSIN-II ANTAGONIST VALSARTAN AT STEADY-STATE IN HEALTHY, NORMOTENSIVE SUBJECTS, European Journal of Clinical Pharmacology, 52(6), 1997, pp. 441-449
Authors:
BINDSCHEDLER M
DEGEN P
FLESCH G
DEGASPARO M
PREISWERK G
Citation: M. Bindschedler et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION OF SINGLE ORAL DOSES OF VALSARTAN AND FUROSEMIDE, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 371-378
Citation: L. Chow et al., BLOCKADE OF ANGIOTENSIN-CONVERTING ENZYME BUT NOT OF ANGIOTENSIN AT(1) RECEPTORS IMPROVES GLUCOSE-TOLERANCE, European journal of pharmacology, 319(1), 1997, pp. 77-83
Authors:
SPINALE FG
DEGASPARO M
WHITEBREAD S
HEBBAR L
CLAIR MJ
MELTON DM
KROMBACH RS
MUKHERJEE R
IANNINI JP
O SJ
Citation: Fg. Spinale et al., MODULATION OF THE RENIN-ANGIOTENSIN PATHWAY THROUGH ENZYME-INHIBITIONAND SPECIFIC RECEPTOR BLOCKADE IN PACING-INDUCED HEART-FAILURE .1. EFFECTS ON LEFT-VENTRICULAR PERFORMANCE AND NEUROHORMONAL SYSTEMS, Circulation, 96(7), 1997, pp. 2385-2396
Authors:
SPINALE FG
MUKHERJEE R
IANNINI JP
WHITEBREAD S
HEBBAR L
CLAIR MJ
MELTON DM
COX MH
THOMAS PB
DEGASPARO M
Citation: Fg. Spinale et al., MODULATION OF THE RENIN-ANGIOTENSIN PATHWAY THROUGH ENZYME-INHIBITIONAND SPECIFIC RECEPTOR BLOCKADE IN PACING-INDUCED HEART-FAILURE .2. EFFECTS ON MYOCYTE CONTRACTILE PROCESSES, Circulation, 96(7), 1997, pp. 2397-2406
Authors:
KALENGA MK
THOMAS K
DEGASPARO M
DEHERTOGH R
Citation: Mk. Kalenga et al., DETERMINATION OF RENIN, ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN-II LEVELS IN HUMAN PLACENTA, CHORION AND AMNION FROM WOMEN WITH PREGNANCY-INDUCED HYPERTENSION, Clinical endocrinology, 44(4), 1996, pp. 429-433
Authors:
ROGG H
DEGASPARO M
GRAEDEL E
STULZ P
BURKART F
EBERHARD M
ERNE P
Citation: H. Rogg et al., ANGIOTENSIN II-RECEPTOR SUBTYPES IN HUMAN ATRIA AND EVIDENCE FOR ALTERATIONS IN PATIENTS WITH CARDIAC DYSFUNCTION, European heart journal, 17(7), 1996, pp. 1112-1120
Authors:
BRINK M
ERNE P
DEGASPARO M
ROGG H
SCHMID A
STULZ P
BULLOCK G
Citation: M. Brink et al., LOCALIZATION OF THE ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE HUMAN ATRIUM, Journal of Molecular and Cellular Cardiology, 28(8), 1996, pp. 1789-1799
Authors:
KALENGA MK
DEGASPARO M
THOMAS K
DEHERTOGH R
Citation: Mk. Kalenga et al., DOWN-REGULATION OF ANGIOTENSIN AT(1) RECEPTOR BY PROGESTERONE IN HUMAN PLACENTA, The Journal of clinical endocrinology and metabolism, 81(3), 1996, pp. 998-1002
Authors:
LAFLAMME L
DEGASPARO M
GALLO JM
PAYET MD
GALLOPAYET N
Citation: L. Laflamme et al., ANGIOTENSIN-II INDUCTION OF NEURITE OUTGROWTH BY AT(2) RECEPTORS IN NG108-15, CELLS - EFFECT COUNTERACTED BY THE AT(1) RECEPTORS, The Journal of biological chemistry, 271(37), 1996, pp. 22729-22735